Trospectomycin Enhances Surface Phagocytosis of Bacteroides and Staphylococcus by Altering the Bacterial Glycocalyx

Beachey, 1981, Bacterial adherence: adhesion receptor interactions mediating the attachment of bacteria to mucosal surfaces, J. Infect. Dis., 143, 325, 10.1093/infdis/143.3.325 Bjornson, 1984, Role of complement in host resistance against members of the Bacteroidaceae, Rev. Infect. Dis., 6, S34, 10.1093/clinids/6.Supplement_1.S34 Bjornson, 1978, Participation of immunoglobulin and the alternative complement pathway in opsonization of Bacteroides fragilis and Bacteroides thetaiotaomicron, J. Infect. Dis., 138, 351, 10.1093/infdis/138.3.351 Bjornson, 1983, Quantitative variability in requirement for opsonization of strains within the Bacteroides fragilis group, J. Infect. Dis., 148, 667, 10.1093/infdis/148.4.667 Boyum, 1968, Isolation of mononuclear cells and granulocytes from human blood, Scand. J. Clin. Lab. Invest., 97, S77 Brook, 1986, Encapsulated anaerobic bacteria in synergistic infections, Microbiol. Rev., 50, 452, 10.1128/MMBR.50.4.452-457.1986 Brook, 1987, Bacteraemia and seeding of capsulate Bacteroides ssp. and anaerobic cocci, J. Med. Microbiol., 23, 61, 10.1099/00222615-23-1-61 Brooks, 1983, Osteomyelitis, 1318 Cialdella, 1987, The effects of trospectomycin on serum lysis and polymorphonuclear leukocyte killing of Escherichia coli Connolly, 1984, The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing, J. Med. Microbiol., 17, 259, 10.1099/00222615-17-3-259 Ferguson, 1978, Nutritional requirements of anaerobic coryneforms, J. Bact., 135, 858, 10.1128/JB.135.3.858-867.1978 Geesey, 1982, Microbial exopolymers: Ecological and economic considerations, 9, ASM News, 48 Gemmell, 1983, Antibioticinduced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes, Eur. J. Clin. Microbiol., 2, 327, 10.1007/BF02019462 Grasso, 1984, Inhibition of yeast phagocytosis in macrophage cultures treated with slime polysaccharide purified from Pseudomonas aeruginosa, J. Leukocyte Biol., 36, 771, 10.1002/jlb.36.6.771 Hall, 1984, Roche Susceptibility Test (RST) Medium, a defined formulation for susceptiblity testing. I. Nutrient and optimization studies., J. Microbiol. Meth., 2, 203, 10.1016/0167-7012(84)90015-0 Horn, 1985, An improved fluorochrome microassay for the detection of living and non-living intracellular bacteria in human neutrophils, J. Immunol. Meth., 83, 233, 10.1016/0022-1759(85)90245-5 Jacobus, 1988, Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species, Antimicrob. Agents Chemother., 32, 584, 10.1128/AAC.32.4.584 Jones, 1986, Effects of Bacteroides asaccharolyticus cells and B. fragilis surface components on serum opsonisation and phagocytosis, J. Med. Microbiol., 22, 225, 10.1099/00222615-22-3-225 Keleti, 1974, 51 Laborde, 1987, Mechanism of action of trospectomycin, a novel spectinomycin analog Lambe, 1985 Lambe, 1988, The Bacteroides glycocalyx as visualized by differential interference microscopy, Can. J. Microbiol., 34, 1189, 10.1139/m88-209 Lambe, 1984, Morphological stabilization of the glycocalyces of 23 strains of five Bacteroides species using specific antiserum, Can. J. Microbiol., 30, 809, 10.1139/m84-124 Lambe, 1987, The effect of subinhibitory concentrations of clindamycin on the adherence and glycocalyx of Staphylococcus aureus and Bacteroides species in vitro and in vivo, 35 Lambe, 1987, The role of anaerobes in foreign body-associated osteomyelitis, 36 Mayberry, 1980, Hydroxy fatty acids in Bacteroides species: D-(-)-3-hydroxy-15-methylhexadecanoate and its homologs, J. Bact., 143, 582, 10.1128/JB.143.2.582-587.1980 Mayberry, 1980, Cellular distribution and linkage of D-(-)-3-hydroxy fatty acids in Bacteroides species, J. Bact., 144, 200, 10.1128/JB.144.1.200-204.1980 Onderdonk, 1977, The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains, J. Infect. Dis., 136, 82, 10.1093/infdis/136.1.82 Simon, 1982, Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide, J. Infect. Dis., 145, 72, 10.1093/infdis/145.1.72 Stevens, 1987, Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity, J. Immunol., 121, 2174, 10.4049/jimmunol.121.6.2174 Tofte, 1980, Opsonization of four Bacteroides species: Role of the classical complement pathway and immunoglobulin, Infect. Immun., 27, 784, 10.1128/IAI.27.3.784-792.1980 Vandenbroucke-Grauls, 1984, Interaction between human polymorphonuclear leucocytes and Staphylococcus aureus in the presence and absence of opsonins, Immunology, 52, 427 Van Oss, 1972, Phagocytosis as a surface phenomenon. I. Contact angles and phagocytosis of non-opsonized bacteria, J. Reticuloendothel. Soc., 12, 283 Van Oss, 1972, Phagocytosis as a surface phenomenon. II. Contact angles and phagocytosis of encapsulated bacteria before and after opsonization by specific antiserum and complement, J. Reticuloendothel Soc., 12, 497 Verbrugh, 1987, Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leukocytes, J. Clin. Path., 31, 539, 10.1136/jcp.31.6.539 Veringa, 1989, Phagocytosis of Bacteroides in suspension and on a glass surface determined by a modified fluorochrome assay, J. Microbiol. Meth., 9, 99, 10.1016/0167-7012(89)90060-2 Veringa, 1989, The role of glycocalyx in surface phagocytosis of Bacteroides spp., in the presence or absence of clindamycin, J. Antimicrob. Chemother., 23, 711, 10.1093/jac/23.5.711 Veringa, 1989, Enhancement of opsonophagocytosis of Bacteroides spp. by clindamycin in subinhibitory concentrations, J. Antimicrob. Chemother., 23, 577, 10.1093/jac/23.4.577 Waldvogel, 1985, Staphylococcus aureus, 1097 Ward, 1980, The microbial cell surface and adhesion, 47 Zurenco, 1988, In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog, Antimicrob. Agents Chemother., 32, 216, 10.1128/AAC.32.2.216